Please sign in to follow a disease.
Which exercise is better for the COPD brain? scientists compare steady vs. burst workouts
NCT ID NCT07707271
First seen Jul 16, 2026 · Last updated Sep 11, 2026 · Updated 3 times
Summary
This study looks at how two different exercise styles—steady moderate cycling versus short, intense bursts—affect brain oxygen levels, breathing, and heart function in people with COPD. Researchers will measure changes in brain oxygenation and other body responses during rest, exercise, and recovery. The goal is to find out which type of exercise might be better for improving exercise tolerance in pulmonary rehabilitation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- moderate intensity continuous aerobic exercise (MICE) and high-intensity interval aerobic exercise (HIIE) on a cycle ergometer
- What this could lead to
- If results show one exercise type better supports brain oxygenation, it could guide safer, more effective pulmonary rehabilitation for COPD patients.
- What could go wrong
- This is a very small, early study (12 people) measuring only immediate, short-term changes. It does not test long-term benefits or outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 12 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Clinical diagnosis of COPD based on smoking history (pack/years) or exposure to other risk factors and post bronchodilation forced expiratory volume (FEV1) to forced vital capacity (FVC) ratio \<0.7 * Resting arterial oxygen partial pressure at room air \>60 mmHg, according to recent (within a week) arterial blood gases assessment * Disease being stable and treated optimal, based on current GOLD guidelines. * Provision of informed written signed consent prior to study entry Exclusion Criteria: * Recent respiratory infection or exacerbation (as indicated by deterioration of respiratory symptoms, hospital admission and/or change in medication within the previous month), within the past 3 months * Changes in COPD medication with the past month * History of asthma and/or reversible airway obstruction (post bronchodilation FEV1/ FVC \>0.7) * Pulmonary hypertension * Congestive heart failure (Left Ventricle Ejection Fraction \<50% in recent echocardiography) * Severe peripheral artery disease * Chronic Kidney disease with eGFR \< 30 ml/min (KDIGO stages 3b, 4 ,5) * Active acute or chronic infectious diseases * Active malignant disease or hematologic disorder under treatment * History of neuromuscular disorder * History of severe intellectual disability or mental disorder * Any contradiction to moderate-high intensity exercise or cardiopulmonary exercise testing according to ATS/ACCP guidelines, such as: myocardial infarction within the past 6 months, unstable angina, syncope, symptomatic severe aortic stenosis, uncontrolled arrhythmias causing symptoms or hemodynamic compromise, acute pulmonary embolus or pulmonary infarction, thrombosis of lower extremities, suspected dissecting aneurysm, pulmonary edema, severe untreated arterial hypertension at rest (\> 200 mm Hg systolic, \> 120 mm Hg diastolic blood pressure), orthopedic impairment that compromises exercise performance.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
George Papanikolaou General Hoapital of Thessaloniki
RECRUITINGThessaloniki, Exohi, 57010, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Device-Preserved donor lungs boost transplant success?
- Tiny One-Way valves for emphysema under close watch in japan
- Is RSV a hidden driver of severe COPD attacks?
- Can Mountain-Air rehab loosen stiff COPD airways?
- Can a breath of extra oxygen boost lung rehab?
- Can a handheld breathing device and phone app help COPD patients breathe easier?